Skip to main content

Table 1 DNA markers used for comparison of genetic alterations in estrogen receptor-negative cells and estrogen receptor-positive cells

From: Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion

Marker Name Chromosomal location Harbored gene Size (base pairs)
1 D3S1300 3p21.1–p14.2 FHIT 217–241
2 D3S1481 3p14.2 FHIT 104
3 D3S1581 3p21.2–p14.2 FHIT 78–102
4 D11S902 11p15–p13 ? 145–163
5 D11S904 11p14–p13 Wilms' tumor 1 185–201
6 D11S907 11p13 Wilms' tumor 1 163–173
7 D11S914 11p13–p12 Wilms' tumor 1 275–285
8 D13S119 13q14.3–q22 ? 124–140
9 D13S173 13q32–q34 ? 166–178
10 D13S219 13q12.3–q13 ? 117–127
11 D13S263 13q14.1–q14.2 ? 145–165
12 D16S518 16q23.1–q24.2 CDH 1 (adjacent to it) 272–290
13 D16S402 16q24.2 CDH 1 (adjacent to it) 161–187
14 D17S791 17q BRCA 1 165–199
15 TP53 17p13 P53 104
  1. FHIT, fragile histidine triad.